Sagespring Wealth Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$550K Buy
7,774
+107
+1% +$8.01K 0.01% 473
2025
Q4
$605K Sell
7,667
-341
-4% -$27K 0.01% 428
2025
Q3
$660K Buy
8,008
+377
+5% +$29.7K 0.01% 398
2025
Q2
$614K Buy
7,631
+1,791
+31% +$138K 0.01% 381
2025
Q1
$469K Buy
5,840
+508
+10% +$42.2K 0.01% 405
2024
Q4
$437K Buy
+5,332
New +$444K 0.01% 379

Other funds holding MET

Sagespring Wealth Partners's MET Position: Q1 2026 in Review

Sagespring Wealth Partners increased its MetLife (MET) stake by 1.4% in Q1 2026, buying an estimated $8.01K and bringing the position to 7,774 shares worth $550K. The position accounts for 0.01% of the portfolio, ranked #473.

Sagespring Wealth Partners first reported a position in MET in Q4 2024 and has held it in 6 quarters since. The position peaked at $660K in Q3 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Sagespring Wealth Partners held 7,774 shares of MetLife worth $550K as of Q1 2026.
  • Sagespring Wealth Partners bought 107 MetLife shares in Q1 2026, an estimated $8.01K.
  • MetLife made up 0.01% of Sagespring Wealth Partners's portfolio in Q1 2026, its #473 holding.
  • Sagespring Wealth Partners first reported a position in MetLife in Q4 2024 and has held it in 6 quarters since.
  • Sagespring Wealth Partners's MetLife position peaked at $660K in Q3 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Sagespring Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.